Myths vs facts: ApoB and Darmgesundheit

ApoB (apolipoprotein B) is a core protein in atherogenic lipoproteins like LDL. Gut health can influence ApoB levels – for instance via the gut microbiota, which regulates bile acid metabolism and inflammatory pathways. Studies show that altered microbiota composition is associated with higher ApoB levels. However, evidence is mostly observational; causal interventions (e.g., probiotics) show mixed results. A myth is that ApoB only matters for cardiovascular disease – in fact, a disrupted gut barrier ('leaky gut') can promote systemic inflammation, which in turn may increase hepatic lipoprotein production. Another myth: a gut test alone can predict ApoB risk. This is unsubstantiated; ApoB should be measured in fasting blood. The clinical relevance of the gut–ApoB axis is not yet sufficiently validated to guide recommendations. Beware of exaggerated marketing claims. Evidence: human-moderate.